Insider Transactions in Q2 2021 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,704
-0.26%
|
$223,416
$29.6 P/Share
|
|
Jun 24
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,000
-0.33%
|
$290,000
$29.9 P/Share
|
|
Jun 23
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,980
-1.25%
|
$1,101,420
$29.8 P/Share
|
|
Jun 22
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
110,000
-3.49%
|
$3,080,000
$28.5 P/Share
|
|
Jun 21
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
91,620
-2.82%
|
$2,656,980
$29.7 P/Share
|
|
Jun 15
2021
|
Michael Ackermann Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,257
+0.34%
|
-
|
|
May 07
2021
|
Rtw Investments, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
450,000
-18.27%
|
$13,050,000
$29.98 P/Share
|
|
Apr 14
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
400
-0.01%
|
$12,000
$30.37 P/Share
|